ORMP icon

Oramed Pharmaceuticals
ORMP

Overview Fund Activity

27 hedge funds and large institutions have $3.4M invested in Oramed Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 1 closing their positions.

Holders
27
Holders Change
+5
Holders Change %
+22.73%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
9
Reduced
3
Closed
1
Calls
$9K
Puts
$28K
Net Calls
-$19K
Net Calls Change
+$3K

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$324K
2
Millennium Management
2
Millennium Management
New York
$143K
3
UBS Group
3
UBS Group
Switzerland
$157K
4
OAM
4
Oxford Asset Management
United Kingdom
$116K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$842K

Top Sellers

1
Wells Fargo
1
Wells Fargo
California
$94K
2
PMFA
2
Plante Moran Financial Advisors
Michigan
$0
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$166K
4
TRCT
4
Tower Research Capital (TRC)
New York
$1K
Name Market Value Shares Shares
Change 		Shares
Change %
SPIA
26
Steward Partners Investment Advisory
New York
$2K 300 +300 New
TRCT
27
Tower Research Capital (TRC)
New York
$1K 131 -262 -67%
PMFA
28
Plante Moran Financial Advisors
Michigan
– – -300 Closed
Simplex Trading
29
Simplex Trading
Illinois
– – – –
1
2